Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 190

Similar articles for PubMed (Select 20215131)

1.

Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.

Dutkowski R.

J Antimicrob Chemother. 2010 Apr;65 Suppl 2:ii11-ii24. doi: 10.1093/jac/dkq012. Review.

2.

Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir.

Reddy D.

J Antimicrob Chemother. 2010 Apr;65 Suppl 2:ii35-ii40. doi: 10.1093/jac/dkq014. Review.

3.

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.

Matsuzaki Y, Mizuta K, Aoki Y, Suto A, Abiko C, Sanjoh K, Sugawara K, Takashita E, Itagaki T, Katsushima Y, Ujike M, Obuchi M, Odagiri T, Tashiro M.

Virol J. 2010 Mar 5;7:53. doi: 10.1186/1743-422X-7-53.

4.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
5.

Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.

Dharan NJ, Beekmann SE, Fiore A, Finelli L, Uyeki TM, Polgreen PM, Fry AM.

Antiviral Res. 2010 Nov;88(2):182-6. doi: 10.1016/j.antiviral.2010.08.010. Epub 2010 Aug 23.

PMID:
20739002
6.

Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.

Kawai N, Ikematsu H, Iwaki N, Kondou K, Hirotsu N, Kawashima T, Maeda T, Tanaka O, Doniwa K, Iwakuni O, Egashira K, Yamaji K, Kashiwagi S.

J Infect Chemother. 2012 Apr;18(2):180-6. doi: 10.1007/s10156-011-0314-2. Epub 2011 Dec 23.

PMID:
22193710
7.

Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.

Zaraket H, Saito R, Wakim R, Tabet C, Medlej F, Reda M, Baranovich T, Suzuki Y, Dapat C, Caperig-Dapat I, Dbaibo GS, Suzuki H.

J Med Virol. 2010 Jul;82(7):1224-8. doi: 10.1002/jmv.21795.

PMID:
20513088
8.

Influenza virus susceptibility and resistance to oseltamivir.

Aoki FY, Boivin G, Roberts N.

Antivir Ther. 2007;12(4 Pt B):603-16. Review.

PMID:
17944268
9.

Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.

Renaud C, Kuypers J, Englund JA.

J Clin Virol. 2011 Oct;52(2):70-8. doi: 10.1016/j.jcv.2011.05.019. Epub 2011 Jun 17. Review.

PMID:
21684202
10.

Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses.

Ciancio BC, Meerhoff TJ, Kramarz P, Bonmarin I, Borgen K, Boucher CA, Buchholz U, Buda S, Dijkstra F, Dudman S, Duwe S, Hauge SH, Hungnes O, Meijer A, Mossong J, Paget WJ, Phin N, van der Sande M, Schweiger B, Nicoll A.

Euro Surveill. 2009 Nov 19;14(46). pii: 19412.

11.

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, St George K, Epperson S, Brammer L, Klimov AI, Bresee JS, Fry AM; Oseltamivir-Resistance Working Group.

JAMA. 2009 Mar 11;301(10):1034-41. doi: 10.1001/jama.2009.294. Epub 2009 Mar 2.

PMID:
19255110
12.

Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.

Wang B, Dwyer DE, Blyth CC, Soedjono M, Shi H, Kesson A, Ratnamohan M, McPhie K, Cunningham AL, Saksena NK.

Antiviral Res. 2010 Jul;87(1):16-21. doi: 10.1016/j.antiviral.2010.04.002. Epub 2010 Apr 10.

PMID:
20385168
13.

Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.

Zaraket H, Saito R, Suzuki Y, Baranovich T, Dapat C, Caperig-Dapat I, Suzuki H.

J Clin Microbiol. 2010 Apr;48(4):1085-92. doi: 10.1128/JCM.01532-09. Epub 2010 Feb 3.

14.

Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.

Smith JR, Rayner CR, Donner B, Wollenhaupt M, Klumpp K, Dutkowski R.

Adv Ther. 2011 Nov;28(11):927-59. doi: 10.1007/s12325-011-0072-7. Epub 2011 Nov 1. Review.

PMID:
22057727
15.

Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.

Ledesma J, Vicente D, Pozo F, Cilla G, Castro SP, Fernández JS, Ruiz MP, Navarro JM, Galán JC, Fernández M, Reina J, Larrauri A, Cuevas MT, Casas I, Breña PP; Spanish Influenza Surveillance System (SISS).

J Clin Virol. 2011 Jul;51(3):205-8. doi: 10.1016/j.jcv.2011.04.008. Epub 2011 May 17.

PMID:
21592854
16.

Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.

Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, Caperig-Dapat I, Oguma T, Shabana II, Saito T, Suzuki H; Japanese Influenza Collaborative Study Group.

J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003. Epub 2009 Dec 3.

PMID:
19962344
17.

Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.

Ikematsu H, Kawai N.

Expert Rev Anti Infect Ther. 2011 Oct;9(10):851-7. doi: 10.1586/eri.11.112. Review.

PMID:
21973296
18.

Clinical importance and impact on the households of oseltamivir-resistant seasonal A/H1N1 influenza virus in healthy children in Italy.

Esposito S, Molteni CG, Daleno C, Valzano A, Fossali E, Da Dalt L, Cecinati V, Bruzzese E, Giacchino R, Giaquinto C, Galeone C, Lackenby A, Principi N.

Virol J. 2010 Aug 26;7:202. doi: 10.1186/1743-422X-7-202.

19.

Comparisons of oseltamivir-resistant (H275Y) and concurrent oseltamivir-susceptible seasonal influenza A(H1N1) virus infections in hospitalized adults, 2008-2009.

Chan MC, Lee N, Lui GC, Ngai KK, Wong RY, Choi KW, Chan PK.

Influenza Other Respir Viruses. 2013 May;7(3):235-9. doi: 10.1111/j.1750-2659.2012.00387.x. Epub 2012 Jun 14.

PMID:
22694153
20.

Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.

Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, Reisdorf E, St George K, Myers R, Wotton JT, Robinson S, Leader B, Thompson M, Shannon M, Klimov A, Fry AM; US Antiviral Resistance Surveillance Working Group.

Emerg Infect Dis. 2012 Feb;18(2):308-11. doi: 10.3201/eid1802.111466.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk